Naomi L. Cook

Naomi L. Cook

Auto-generated profile, based on publicly available information

Naomi L. Cook

The Heart Research Institute, Newtown, Sydney, NSW 2042, Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Genome Biology
Verified
Journal Article
Open access
PDF file
BBBrunilda Balliu
Brunilda Balliu
MDMatthew Durrant
Matthew Durrant
OGOlivia de Goede
Olivia de Goede
NANathan Abell
Nathan Abell
XLXin Li
Xin Li
SMStephen B. Montgomery
Stephen B. Montgomery
Background: Molecular and cellular changes are intrinsic to aging and age-related diseases. Prior cross-sectional studies have investigated the combined effects of age and genetics on gene expression and alternative splicing; however, there has been no long-term, longitudinal characterization of these molecular changes, especially in older age. Results: We perform RNA sequencing in whole blood from the same individuals at ages 70 and 80 to quantify how gene expression, alternative splicing, and their genetic regulation are altered during this 10-year period of advanced aging at a population and individual level. We observe that individuals are more similar to their own expression profiles later in life than profiles of other individuals their own age. We identify 1291 and 294 genes differentially expressed and alternatively spliced with age, as well as 529 genes with outlying individual trajectories. Further, we observe a strong correlation of genetic effects on expression and splicing between the two ages, with a small subset of tested genes showing a reduction in genetic associations with expression and splicing in older age. Conclusions: These findings demonstrate that, although the transcriptome and its genetic regulation is mostly stable late in life, a small subset of genes is dynamic and is characterized by a reduction in genetic regulation, most likely due to increasing environmental variance with age.

6 June 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CNChristoph Nowak
Christoph Nowak
SHSusanne Hetty
Susanne Hetty
SSSamira Salihovic
Samira Salihovic
CCCasimiro Castillejo-Lopez
Casimiro Castillejo-Lopez
AGAndrea Ganna
Andrea Ganna
EIErik Ingelsson
Erik Ingelsson
Insulin resistance (IR) predisposes to type 2 diabetes and cardiovascular disease but its causes are incompletely understood. Metabolic challenges like the oral glucose tolerance test (OGTT) can reveal pathogenic mechanisms. We aimed to discover associations of IR with metabolite trajectories during OGTT. In 470 non-diabetic men (age 70.6 ± 0.6 years), plasma samples obtained at 0, 30 and 120 minutes during an OGTT were analyzed by untargeted liquid chromatography-mass spectrometry metabolomics. IR was assessed with the hyperinsulinemic-euglycemic clamp method. We applied age-adjusted linear regression to identify metabolites whose concentration change was related to IR. Nine trajectories, including monounsaturated fatty acids, lysophosphatidylethanolamines and a bile acid, were significantly associated with IR, with the strongest associations observed for medium-chain acylcarnitines C10 and C12, and no associations with L-carnitine or C2-, C8-, C14- or C16-carnitine. Concentrations of C10- and C12-carnitine decreased during OGTT with a blunted decline in participants with worse insulin resistance. Associations persisted after adjustment for obesity, fasting insulin and fasting glucose. In mouse 3T3-L1 adipocytes exposed to different acylcarnitines, we observed blunted insulin-stimulated glucose uptake after treatment with C10- or C12-carnitine. In conclusion, our results identify medium-chain acylcarnitines as possible contributors to IR.

19 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MFMohsen Fathzadeh
Mohsen Fathzadeh
JLJiehan Li
Jiehan Li
ARAbhiram Rao
Abhiram Rao
NCNaomi Cook
Naomi Cook
ICIndumathi Chennamsetty
Indumathi Chennamsetty
JKJosh Knowles
Josh Knowles
Genetic variation in the FAM13A (Family with Sequence Similarity 13 Member A) locus has been associated with several glycemic and metabolic traits in genome-wide association studies (GWAS). Here, we demonstrate that in humans, FAM13A alleles are associated with increased FAM13A expression in subcutaneous adipose tissue (SAT) and an insulin resistance-related phenotype (e.g. higher waist-to-hip ratio and fasting insulin levels, but lower body fat). In human adipocyte models, knockdown of FAM13A in preadipocytes accelerates adipocyte differentiation. In mice, Fam13a knockout (KO) have a lower visceral to subcutaneous fat (VAT/SAT) ratio after high-fat diet challenge, in comparison to their wild-type counterparts. Subcutaneous adipocytes in KO mice show a size distribution shift toward an increased number of smaller adipocytes, along with an improved adipogenic potential. Our results indicate that GWAS-associated variants within the FAM13A locus alter adipose FAM13A expression, which in turn, regulates adipocyte differentiation and contribute to changes in body fat distribution.

18 August 2008 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
NCNaomi L. Cook
Naomi L. Cook
RVRobert Vink
Robert Vink
JDJames J. Donkin
James J. Donkin
CHCorinna van Den Heuvel
Corinna van Den Heuvel

1 February 2015 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
NCNaomi L. Cook
Naomi L. Cook
TPTamara N. Pereira
Tamara N. Pereira
PLPeter J. Lewindon
Peter J. Lewindon
RSRoss W. Shepherd
Ross W. Shepherd
GRGrant A. Ramm
Grant A. Ramm

1 March 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
NCNaomi L. Cook
Naomi L. Cook
HVHelena M. Viola
Helena M. Viola
VSVictor S. Sharov
Victor S. Sharov
LHLivia Hool
Livia Hool
CSChristian Schöneich
Christian Schöneich
Michael DaviesMichael Davies
Michael Davies
The sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) plays a critical role in Ca(2+) homeostasis via sequestration of this ion in the sarco/endoplasmic reticulum. The activity of this pump is inhibited by oxidants and impaired in aging tissues and cardiovascular disease. We have shown previously that the myeloperoxidase (MPO)-derived oxidants HOCl and HOSCN target thiols and mediate cellular dysfunction. As SERCA contains Cys residues critical to ATPase activity, we hypothesized that HOCl and HOSCN might inhibit SERCA activity, via thiol oxidation, and increase cytosolic Ca(2+) levels in human coronary artery endothelial cells (HCAEC). Exposure of sarcoplasmic reticulum vesicles to preformed or enzymatically generated HOCl and HOSCN resulted in a concentration-dependent decrease in ATPase activity; this was also inhibited by the SERCA inhibitor thapsigargin. Decomposed HOSCN and incomplete MPO enzyme systems did not decrease activity. Loss of ATPase activity occurred concurrent with oxidation of SERCA Cys residues and protein modification. Exposure of HCAEC, with or without external Ca(2+), to HOSCN or HOCl resulted in a time- and concentration-dependent increase in intracellular Ca(2+) under conditions that did not result in immediate loss of cell viability. Thapsigargin, but not inhibitors of plasma membrane or mitochondrial Ca(2+) pumps/channels, completely attenuated the increase in intracellular Ca(2+) consistent with a critical role for SERCA in maintaining endothelial cell Ca(2+) homeostasis. Angiotensin II pretreatment potentiated the effect of HOSCN at low concentrations. MPO-mediated modulation of intracellular Ca(2+) levels may exacerbate endothelial dysfunction, a key early event in atherosclerosis, and be more marked in smokers because of their higher SCN(-) levels.